Business Summary Management Board of Directors Joint Auditors Company Registrar Subsidiaries/Associates Capital Structure

   GLAXOSMITH

Select Quote:
Index: 37350.53 878.10 2.41%
Business Summary Management Board of Directors Company Secretary Company Registrars Subsidiaries/Associates Joint Auditors Quote Login
Sector:
Healthcare
Sub-Sector:
Pharmaceuticals
Listing Date:
July, 1979
End of Accounting Year:
31 Dec
Share Outstanding:
956,701,190.00
NSE code
GLAXOSMITH
AGM Date:
23-05-2013


You need to upgrade your Flash Player
You need to upgrade your Flash Player
You need to upgrade your Flash Player
You need to upgrade your Flash Player

No. Of Deals:   35.00

Volume Traded:   260,437.00

Value Traded:    14,454,649.20

52 Weeks High:  58.00

52 Weeks Low:    20.00

Open Price:    58.00

Close Price:    58.00

High Price:    58.00

Low Price:    58.00

Year To Date Appreciation:   315.77 

 

1 Week Change (%)

1 Month Change (%)

6 Months Change (%)

1 Year Change (%)

GLAXOSMITH

18.37

18.37

54.63

190

NSE All-share Index

1.2

11.72

41.9

68.11

Quarterly Results For GLAXOSMITH

2nd May, 2013: 1st Quarter Results for the Period Ending 31-Mar-2013


Values
2013 N'm
2012 N'm
% Change
Profit & Loss Information
Turnover
6,927
25,308
-72.63%
Cost of Sales
-4,216
-15,080
-72.04%
Profit Before Tax
865
4,171
-79.27%
Taxation
-268
-1,348
-80.11%
Profit Or Loss After Tax
597
2,823
-78.86%
Balance Sheet Information
Fixed Assets
9,696
8,835
9.75%
Net Assets
11,259
10,663
5.59%
  VALUATION MEASURES
Market Cap :
55,488,669,020.00
EPS:
0.62
P/E:
92.99
Book Value :
N/A
Book Value Per Share :
N/A
Price/Book
N/A
  FINANCIAL HIGHLIGHTS
  Fiscal
Fiscal Year End
31 Dec
Most Recent Quarter
1st Quarter
  Profitability
Profit Before Tax Margin
12.48
Profit After Tax Margin
8.61
Profit Before Tax Growth
-79.27
Profit After Tax Growth
-78.86
  Management Effectiveness
Return On Assets
0.06
Return On Equity
0.05


  INCOME STATEMENT
Revenue:
N6,927.00(mln)
Revenue Per Share :
7.24
Revenue Growth :
-72.63%
   Balance Sheet
Total Cash
0.00
Shareholder Fund Growth
5.59%
Loan Growth
0.00%
Deposit Growth
0.00%
Fixed Asset Growth
9.75%
  Dividends & Splits
Dividend:
1.30 (2013-04-23)
Bonus Declared
1 for 5 (2005-05-06)
  TRADING INFORMATION
  Stock Price History
52-week Change:
190.00%
52-week Change
(relative to NSE Index)
68.11%
52-Week High:
58.00
52 Week Low :
20.00
50-Day Moving Average :
48.40
200-Day Moving Average:
43.00
  Share Statistics
Ave. Volume (3 month):
182,915.10
Ave. Volume (10 days):
164,242.00
Shares Outstanding:
956,701,190.00
Daily Volume
260,437.00


Glaxo Smith KLine Plc
Balance Sheet as at 31 December 2009
Assets employed
2009
2008
Fixed assets
4,788,426
3,961,995
Current assets
7,289,936
5,649,286
Total Assets
12078362
9611281
Financed by
Share capital
478,350
478,350
Share premium
51,395
51,395
Creditors due within one year
4,625,976
3,321,911
Deferred taxation
407,264
310,607
Provision for liabilities and charges
461,881
527,304
Revaluation reserve
24,721
24,721
General reserve
6,028,775
4,896,993
12078362
9611281
PROFIT AND LOSS ACCOUNTS
For the year ended 31 December 2009
Turnover
14952445
12545129
Gross profit
6,308,149
5,367,390
Profit before interest charges and taxation
2,471,096
1,852,250
Interest charges
1,500
886
Profit before taxation
2,469,596
1,851,364
Taxation
767,767
573,923
Profit after taxation
1,701,829
1,277,441
Profit before taxation as a percentage of turnover
16.5%
14.8%
Proposed dividend
717,526
574,021
Proposed dividend per share (kobo)
75
60
Earnings per share (kobo)
178
134
The Company
Profit before taxation as a percentage of turnover
0
0
Earnings per share (kobo)
165
122
Statement of Cash Flows
For the period ended 31 December 2009
Cash flows from operating activities
Cash generated from operations
3,343,889
2,335,765
Company income tax paid
1,073,200,427
-328,803
Net cash generated from operations
2802492
2006962
Cash flows from investing activities
Purchase of fixed assets
1,072,334,309
-1,002,524
Proceed on disposal of assets
32,229
134,391
Interest Income
105,249
30,831
Net cash used in investing activities
-1270037
-837302
Cash flows from financing activities
Payment of dividend
1,073,167,803
-430,578
Interest paid
-1,500
-886
Net cash used in financing activities
-575521
-431464
Net increase in cash balances
956934
738196
Cash balances at the beginning of the period:
Bank and cash balances
1,192,403
512,329
Bank overdraft
-58,122
Cash and cash equivalent at the end of the period
2149337
1192403
Investment Valuation Ratios
Dividend Per Share
-0
Operating Profit Per Share (Rs)
Profitability Ratios
Operating Profit Margin(%)
Profit Before Interest And Tax Margin(%)
Gross Profit Margin(%)
0.42%
Return On Capital Employed(%)
Return On Net Worth(%)
0.14%
Return on Assets
0%
Liquidity And Solvency Ratios
Current Ratio
Quick Ratio
Debt Equity Ratio
Debt Coverage Ratios
Number of Days In Working Capital
Working Capital
Cash Flow Indicator Ratios
Inventory Turnover Ratio
Earning Retention Ratio
1.34%
Earnings Per Share
0
Fixed Assets Turnover Ratio
3%
OPERATING PROFIT MARGIN
INTEREST COVERAGE
-1,647
DIVIDEND PAYOUT
P/E (x)
P/BV (x)
Turnover growth
0%
PBT Margin (%)
0%
PAT Margin (%)
0%
Announcement Date
Agm Date
Book Closure
Address
--
2009-05-21
--
--
2010-05-25
2010-04-28
4th March, 2011
2011-05-24
2011-04-29
27th Feb, 2012
2012-05-22
2010-04-24
MUSON Centre, Onikan Lagos at 11.00 a.m.
26th March, 2013
2013-05-23
2013-04-23
City Hall, Lagos at 11.00 a.m.
Bonus
Bonus Type
Announcement Date
Payment Date
Closure Date
1 for 5
--
--
--
2005-05-06
1 for 5
--
--
--
2005-05-06
Dividend
Dividend Type
Announcement Date
Payment Date
Closure Date
1.30
FINAL
26th March, 2013
2013-05-24
2013-04-23
1.20
FINAL
27th Feb, 2012
2012-05-23
2012-04-24
0.90
FINAL
4th March, 2011
--
2011-04-29
0.75
FINAL
1st March, 2010
--
2010-04-30
0.12
--
--
--
2002-05-13
0.22
--
--
--
2003-04-28
0.35
--
--
--
2005-05-06
0.4
FINAL
--
--
2006-05-02
0.45
--
--
--
2007-05-04
0.45
--
--
--
2008-05-05
Right Ratio
Face Value
Announcement Date
Record Date
Ex-right Date
Premium
Old Face Value
New Face Value
Announcement Date
Ex-split Date
Meeting Date
Remark/Outcome
`
2011-02-28
To consider and approve its 2010 Audited Financial Statements.
`
2012-02-23
To consider and approve the company’s Audited Financial Statements for the year ended December 31, 2011. To consider the amount to be recommended to members as dividend at its next Annual General Meeting (AGM) and also fix a date and venue for the forth coming general meeting.